🟢 HCW Biologics is trading 11.2% up today as it rebounds from a sharp selloff following an FDA meeting request update

HCW Biologics is trading at $2.78 (11.2%) up today, rebounding after a sharp multi-day selloff that saw the price drop from above $4 to $2.50.

• The move follows recent volatility surrounding the company’s July 23 announcement that it requested a Type B pre-IND FDA meeting for lead candidate HCW11-018b.
• Investors remain focused on the company's oncology pipeline and regulatory progress as it recovers from its recent downward trend.